candesartan has been researched along with atenolol in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (50.00) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Funakoshi, J; Kakumoto, M; Okumura, K; Sakaeda, T; Takara, K; Tanigawara, Y | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Rapi, J | 1 |
| Ferder, L; Inserra, F; Néstor Mazza, O; Stella, I; Toblli, J | 1 |
| Amukotuwa, SA; McLachlan, CS; Mossop, PJ; Nixon, IK | 1 |
| Ariff, B; Barratt, D; Hughes, A; Sever, P; Stanton, A; Thom, S; Vamadeva, S; Xu, Y; Zambanini, A | 1 |
| Han, SH; Kim, SJ; Koh, KK; Koh, Y; Lee, Y; Quon, MJ; Shin, EK | 1 |
| Calzolari, A; Cifra, B; Giannico, S; Giordano, U; Turchetta, A | 1 |
| Abbas, AM; Boshra, V; El Aal, IA; Elkhateeb, M; Saad, MA | 1 |
| Azizi, M; Blanchard, A; Charbit, B; Ezan, E; Funck-Brentano, C; Ménard, J; Peyrard, S; Wuerzner, G | 1 |
2 review(s) available for candesartan and atenolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Irbesartan: a new possibility in the treatment of hypertension].
Topics: Acrylates; Angiotensin Receptor Antagonists; Antihypertensive Agents; Atenolol; Benzimidazoles; Benzoates; Biological Availability; Biphenyl Compounds; Controlled Clinical Trials as Topic; Drug Administration Schedule; Enalapril; Half-Life; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Telmisartan; Tetrazoles; Thiophenes; Valine; Valsartan | 2002 |
3 trial(s) available for candesartan and atenolol
| Article | Year |
|---|---|
Candesartan- and atenolol-based treatments induce different patterns of carotid artery and left ventricular remodeling in hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Atenolol; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Carotid Artery, Common; Compliance; Double-Blind Method; Echocardiography; Female; Humans; Hypertension; Male; Middle Aged; Regional Blood Flow; Tetrazoles; Ventricular Remodeling | 2006 |
Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs.
Topics: Adipokines; Adiponectin; Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Benzimidazoles; Biphenyl Compounds; Cholesterol, HDL; Comorbidity; Endothelium, Vascular; Female; Humans; Hypertension; Male; Middle Aged; Ramipril; Single-Blind Method; Tetrazoles; Triglycerides | 2010 |
Effect of contrasted sodium diets on the pharmacokinetics and pharmacodynamic effects of renin-angiotensin system blockers.
Topics: Adolescent; Adrenergic beta-1 Receptor Antagonists; Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Benzimidazoles; Biphenyl Compounds; Cardiovascular Diseases; Chromatography, Liquid; Cross-Over Studies; Diet, Sodium-Restricted; Dose-Response Relationship, Drug; Electrocardiography; Humans; Immunoradiometric Assay; Male; Ramipril; Reference Values; Renin; Renin-Angiotensin System; Sodium, Dietary; Tetrazoles; Treatment Outcome; Young Adult | 2013 |
9 other study(ies) available for candesartan and atenolol
| Article | Year |
|---|---|
Interaction of digoxin with antihypertensive drugs via MDR1.
Topics: Animals; Antihypertensive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cells, Cultured; Digoxin; Drug Interactions; Humans; Time Factors | 2002 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Protection of cavernous tissue in male spontaneously hypertensive rats. Beyond blood pressure control.
Topics: Actins; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Atenolol; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Pressure; Collagen Type III; Creatinine; Disease Models, Animal; Male; Models, Cardiovascular; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Systole; Tetrazoles | 2004 |
Staged endovascular treatment for complicated type B aortic dissection.
Topics: Acute Disease; Adult; Aorta, Thoracic; Aortic Aneurysm, Thoracic; Aortic Dissection; Atenolol; Back Pain; Benzimidazoles; Biphenyl Compounds; Blood Vessel Prosthesis Implantation; Chest Pain; Humans; Male; Tetrazoles | 2005 |
Mid-term results, and therapeutic management, for patients suffering hypertension after surgical repair of aortic coarctation.
Topics: Adolescent; Antihypertensive Agents; Aortic Coarctation; Atenolol; Benzimidazoles; Biphenyl Compounds; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Male; Postoperative Complications; Tetrazoles; Time Factors | 2009 |
Effect of angiotensin II type 1 receptor blocker, candesartan, and beta 1 adrenoceptor blocker, atenolol, on brain damage in ischemic stroke.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Animals; Atenolol; Behavior, Animal; Benzimidazoles; Biomarkers; Biphenyl Compounds; Brain Ischemia; Case-Control Studies; Creatinine; Disease Models, Animal; Glomerular Filtration Rate; Hemodynamics; Humans; Hypoxia, Brain; Kidney; Male; Plasminogen Inactivators; Rats; Rats, Wistar; Renin; Renin-Angiotensin System; Stroke; Tetrazoles; Time Factors | 2010 |